What is this New Zealand plant that would cure eczema?


A clinical trial shows interesting effects against eczema, thanks to a plant native to New Zealand.

Small blisters, red patches, crusts, itching… L’eczema is the most common skin disease. There are two main types: atopic eczema (general) and contact eczema (localized). It is painful, sometimes invasive, and can significantly impact the quality of life of patients. While there are already treatments, a new option could soon be available, thanks to a plant from New Zealand, as a study explains appeared in The Lancet in July 2022.

This new means of treating eczema would come from kanuka, a very widespread plant from the region of Tairawhiti, which would have the advantage of calm the inflammation of eczema and to act as a brake against the risk of infection that arises from injuries related to this disease.

Anti-bacterial, natural anti-inflammatory

To reach this conclusion, researchers from the New Zealand Institute of Medical Research tested a cream made from 3% kanuka oil on 41 people suffering from moderate to severe forms. Facing them, 39 other people received a placebo. And the result turned out to be satisfactory: symptoms were less severe and the condition of the kanuka-treated group was better six weeks after treatment compared to those who did not receive it.

Natural anti-inflammatory and anti-bacterial, kanuka prepared in this way also has the advantage of not causing any noticeable side effects. This could therefore constitute an interesting alternative to accompany patients who suffer from eczema and which are currently mainly treated with drugs that include cortisone.

As a reminder, the dermatocorticoids used to date have local adverse effects such as skin fragility, difficulty healing, acne, abnormal hair growth, depigmentation or even an increased risk of infection, recalls the site Cortisone Info.

Sources :

  • Efficacy of a 3% Kānuka oil cream for the treatment of moderate-to-severe eczema: A single blind randomised vehicle-controlled trial, The LancetJuly 15, 2022
  • Cortisone-info, Public Assistance Paris Hospitals

Subscribe to the Top Santé Newsletter to receive the latest news for free


Source: Topsante.com by www.topsante.com.

*The article has been translated based on the content of Topsante.com by www.topsante.com. If there is any problem regarding the content, copyright, please leave a report below the article. We will try to process as quickly as possible to protect the rights of the author. Thank you very much!

*We just want readers to access information more quickly and easily with other multilingual content, instead of information only available in a certain language.

*We always respect the copyright of the content of the author and always include the original link of the source article.If the author disagrees, just leave the report below the article, the article will be edited or deleted at the request of the author. Thanks very much! Best regards!